E-Mail Updates

Click here to join
our Electronic Communications.

Upcoming Events.


April 26th 2018 - April 27th 2018

Poster presentation “Pushing the accelerator and releasing the brake: testing the soluble LAG-3 protein (IMP321), an antigen presenting cell activator, together with pembrolizumab in unresectable or metastatic melanoma “

Venue:  The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

May 16th 2018 - May 18th 2018
May 24th 2018 - May 25th 2018

Frédéric Triebel speaks on the subject:

“Two ACTIve Immunotherapies in melanoma (TACTI-mel): results of a phase I trial with metastatic melanoma patients treated with a soluble LAG-3 receptor (LAG-3Ig or eftilagimod alpha) as an antigen presenting (APC) activator combined with pembrolizumab.”

June 1st 2018

Immutep to Participate in the Nasdaq Closing Bell Ceremony at the Nasdaq MarketSite in Times Square, New York on June 1st, 2018

June 20th 2018

BIONNALE  - the largest networking event for life sciences and healthcare industries in the German capital region